Physician profile
George M Eid
NPI 1992778393
$618,591.62
in general payments reported to CMS, 2019-2025
26 companies · $157K in 2025
The $157K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $19K · 2021: $47K · 2022: $102K · 2023: $88K · 2024: $194K · 2025: $157K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $286K · Consulting Fee: $93K · Travel and Lodging: $32K · Food and Beverage: $19K · Education: $9,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $286,145.61 |
| Consulting Fee | $92,896.09 |
| Travel and Lodging | $32,109.12 |
| Food and Beverage | $18,558.85 |
| Education | $9,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $238,093.88 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Lilly USA, LLC | $143,521.90 | 2024-2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $132,151.42 | 2021-2025 | Signia, Ligasure, Sonicision |
| W. L. Gore & Associates, INC. | $31,898.17 | 2019-2025 | Gore Synecor Biomaterial, Product In Development, Gore Enform Preperitoneal Biomaterial |
| Covidien Lp | $19,597.14 | 2019-2020 | |
| Ethicon US, LLC | $18,249.26 | 2022-2025 | Echelon Flex, Linx Reflux Management System |
| Intuitive Surgical, INC. | $11,765.67 | 2019-2025 | |
| Asensus Surgical, INC. | $8,407.31 | 2021 | |
| Medical Device Business Services, INC. | $2,921.46 | 2021-2025 | Monocryl |
| Novo Nordisk As | $2,748.00 | 2020 | |
| Ethicon INC. | $2,525.00 | 2022 | |
| Tela Bio, INC. | $2,033.18 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Coopersurgical, INC. | $1,601.32 | 2019-2022 | |
| Davol INC. | $808.59 | 2019-2021 | |
| Cequr Corporation | $376.52 | 2022-2025 | Cequr Simplicity |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $367.32 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $313.82 | 2023-2025 | Axios, Apollo Esg System, Apollo Esg Nxt System |
| Apollo Endosurgery US INC | $209.72 | 2019-2022 | |
| Distalmotion US | $207.71 | 2025 | Dexter L6 Robot |
| Teleflex LLC | $194.60 | 2025 | Titan Sgs Bailout Chuck, Quikclot |
| Baxter Healthcare | $146.05 | 2024 | |
| Karl Storz Endoscopy-America | $121.36 | 2023 | Image 1 S |
| Innovation Technologies INC | $118.20 | 2025 | Irrisept |
| Gt Metabolic Solutions INC | $92.70 | 2025 | |
| Ethicon Endo-Surgery INC. | $74.52 | 2024 | Echelon; Endopath |
| Heron Therapeutics, INC. | $46.80 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Eid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.